News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
The Cancer Research Institute and The Lustgarten Foundation are excited to announce a new partnership, focused exclusively on supporting pancreatic cancer immunotherapy research. – Cancer Research Institute (CRI)
Photo taken from Cancer Research Institute (CRI)/LinekdIn
Sep 19, 2023, 19:28

The Cancer Research Institute and The Lustgarten Foundation are excited to announce a new partnership, focused exclusively on supporting pancreatic cancer immunotherapy research. – Cancer Research Institute (CRI)

Quoting Cancer Research Institute (CRI) on LinkedIn:

“The Cancer Research Institute and The Lustgarten Foundation are excited to announce a new partnership, focused exclusively on supporting pancreatic cancer immunotherapy research. INSPIRE (Integrated Network for Supporting Pancreatic Cancer Immunotherapy Research Efforts) will encompass the established and ongoing adaptive platform trial, REVOLUTION, evaluating first-line chemo-immunotherapy treatment combinations for patients with metastatic pancreatic adenocarcinoma, and will also expand into new areas of pancreatic immunotherapy research. This next wave in immunotherapy research reflects a shared commitment to transforming pancreatic cancer into a curable disease. Discover: here.”

Source: Cancer Research Institute (CRI)/LinkedIn

cancer Cancer Research Institute (CRI) INSPIRE LinkedIn OncoDaily Oncology Pancreatic Cancer The Lustgarten Foundation
Special Coverage
Blog
Jan 19, 2025, 15:36
Paolo Tarantino: How do you plan to use Datopotamab Deruxtecan for HR+/HER2- MBC?
Science
Jan 19, 2025, 15:26
Andrea Necchi: Thromboembolic and Cardiovascular Adverse Events with PARP Inhibitor Treatment in Patients with mCRPC
Insight
Jan 19, 2025, 15:23
Aleix Prat: Excited to share the results of the SOLTI-ELIPSE trial
Blog
Jan 19, 2025, 15:20
Danish Melanoma Lifetime Achievement Award to Lars Bastholt - Danish Metastatic Melanoma Database
Blog
Jan 19, 2025, 15:16
Caroline N. Smith: Hiring for an Assistant Director, Foundation and Scientific Partnerships at the V Foundation for Cancer Research
Blog
Jan 19, 2025, 15:12
Narjust Florez on the challenges and overwhelming sense of not belonging as a Latina in Medicine
Blog
Jan 19, 2025, 15:11
Monica Bertagnolli: It has been a privilege to serve as Director of NIH under President Joe Biden
Blog
Jan 19, 2025, 15:08
Cathy Eng: Speaking about the rising incidence of early-onset colorectal cancer at Tamron Hall Show
Blog
Jan 19, 2025, 15:04
Pam Mangat-Dhaliwal: How ASCO is putting its commitment to patient advocacy into action
Blog
Jan 19, 2025, 14:53
Dégi László Csaba: Thrilled to announce that I’ll be in Davos for the World Economic Forum
Insight
Jan 19, 2025, 14:52
Aleix Prat: The Katherine phase III updated results are out
Insight
Jan 19, 2025, 14:19
Gustavo Viani: Breaking Barriers in Global Oncology